Related Experiment Video
Updated: Feb 13, 2026
08:07
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
11.8K
Developing TRAIL/TRAIL death receptor-based cancer therapies.
Xun Yuan1,2, Ambikai Gajan2, Qian Chu1
1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.
Cancer Metastasis Reviews
|March 16, 2018
Summary
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) activates apoptosis in cancer cells. Understanding TRAIL pathway regulation aids the development of novel TRAIL-based cancer therapies.
Area of Science:
- Molecular biology
- Immunology
- Cancer research
Background:
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a key mediator of programmed cell death.
- TRAIL initiates apoptosis by binding to death receptors DR4 and DR5.
- The TRAIL pathway's role in tumor-selective apoptosis is crucial for cancer therapy development.
Purpose of the Study:
- To explore the regulatory mechanisms of the TRAIL apoptosis pathway.
- To identify potential therapeutic targets within the TRAIL pathway.
- To advance the development of TRAIL-based cancer treatments.
Main Methods:
- Analysis of TRAIL superfamily signaling.
- Investigation of TRAIL receptor (DR4 and DR5) interactions.
- Examination of agents that modulate TRAIL pathway activity.
Main Results:
- TRAIL binding to DR4/DR5 triggers apoptosis.
- TRAIL, DR4, and DR5 expression can be upregulated by various agents.
- The TRAIL pathway demonstrates tumor-selective apoptotic induction.
Conclusions:
- Understanding TRAIL pathway regulation is vital for cancer therapy.
- TRAIL-based therapies hold promise for human cancer treatment.
- Modulation of TRAIL pathway components can enhance anti-cancer efficacy.
Related Concept Videos
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:31Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:18Autophagic Cell Death
4.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
01:30Overview of Cell Death
10.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K